Search
Vyne Therapeutics Inc
VYNEAdd to Watchlist
0.681USD
+0.030+4.66%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
22.71MMarket Cap
LossP/E TTM
Vyne Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Vyne Therapeutics Inc is 8.15, ranking 161 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.36, which is -199.46% below the recent high of 1.35 and -236.82% above the recent low of -4.58.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.